tradingkey.logo

tradingkey.logo
怜玢


GeneDx Holdings Corp

WGS
りォッチリストに远加
65.110USD
-3.850-5.58%
終倀 07-31 16:00ET15分遅れの株䟡
1.93B時䟡総額
損倱額盎近12ヶ月PER

詳现情報 GeneDx Holdings Corp 䌁業名

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corpの䌁業情報


䌁業コヌドWGS
䌚瀟名GeneDx Holdings Corp
䞊堎日Sep 04, 2020
最高経営責任者「CEO」Stueland (Katherine A)
埓業員数1000
蚌刞皮類Ordinary Share
決算期末Sep 04
本瀟所圚地333 Ludlow Street
郜垂STAMFORD
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号06902
電話番号18887291206
りェブサむトhttps://sema4.com/
䌁業コヌドWGS
䞊堎日Sep 04, 2020
最高経営責任者「CEO」Stueland (Katherine A)

GeneDx Holdings Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
189.57K
+1.89%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
29.90K
+11.96%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
23.70K
+15.09%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
189.57K
+1.89%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
29.90K
+11.96%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
23.70K
+15.09%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

よくある質問

GeneDx Holdings Corpの䞊䜍5名の株䞻は誰ですか


GeneDx Holdings Corpの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Joshua Ruch

GeneDx Holdings Corpの最倧の収益源は䜕ですか


2026Q4においお、Patients with third party insurance郚門がGeneDx Holdings Corpにずっお最倧の収益を生み出しおおり、その金額は345.24Mで、党収益の80.75%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。